Purdue, Lilly Partner on 'Biomedical Revolution'

Posted: Updated:
Purdue President Mitch Daniels says the collaboration "will move us forward in areas core to both institutions." Purdue President Mitch Daniels says the collaboration "will move us forward in areas core to both institutions."
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE LLY) and Purdue University have announced a five-year, $52 million life science research collaboration. The agreement marks Purdue's largest strategic collaboration with a single company. The partnership will initially focus on improved development and delivery of injectable medicines designed to reduce pain. Purdue science, engineering and veterinary medicine researchers will work with the company to harness what Lilly Chief Executive Officer David Ricks calls "the biomedical revolution."

"The biomedical revolution is upon us, but harnessing its full potential will require strong collaboration between academic research centers and industry partners," said Ricks, who earned a bachelor's degree from Purdue. "We look forward to expanding our relationship with Purdue as we work together to discover breakthrough solutions for patients."

Purdue President Mitch Daniels says the collaboration "will move us forward in areas core to both institutions."

Lilly will provide up to $52 million for the research partnership, which will focus in part on improving delivery of injectable pain medicines by decreasing the number of injections and strengthening patient compliance and overall health. The university and company will also work together to develop models to more effectively predict the outcome of new therapies.

In addition to the health impact, Lilly Research Laboratories Chief Operating Offer Andrew Dahlem says the collaboration "strengthens our shared commitment to attract and retain the top engineering and technology talent in Indiana."

The new collaboration will be featured this weekend on Inside INdiana Business Television

  • Perspectives

    • Disagreeing Isn't Inherently Disagreeable

      Most of us have an inherent distaste for conflict. And somewhere along the way, society has reached a conclusion that disagreement is a bad thing. When it comes to business advice and decisions, that conclusion can be deadly. I see two factors that have contributed to the current state of disagreement. One is the national political climate, which is the most polarized I can remember since my father was snarling about those damned hippies. The other is social media, which seems to...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • KAR's Big Carmel Investment About Talent 'Fight'

      KAR Auction Services Inc. (NYSE: KAR) Chief Executive Officer Jim Hallett says a planned $80 million investment in a new Carmel headquarters will serve the company's existing needs and boost talent attraction. Some 900 employees are located at the company's current HQ, and KAR says the new space will house 400 new workers that will be added in the coming years. Hallett says "we're all in a fight for talent," especially in the technology space. He calls central Indiana...

    • INDOT Discusses Timeline For 'North Split' Overhaul

      One of the busiest interchanges in the state is going to be rebuilt. The Indiana Department of Transportation has announced the overhaul of the I-65/I-70 North Split in Indianapolis will include rehabilitation or widening of 32 bridges, adding new bridges and making room for future through-lane capacity on both interstates. The interchange handles some 170,000 cars per day. It was built 50 years ago and INDOT says its "useful life" is nearing the end.

    • GOP: Trump Set For Indiana Visit

      The Indiana Republican Party says President Donald Trump will make an appearance in Indiana next week. Specific details regarding the visit, including a location, have not yet been released. 

    • KAR Auction Services Plans $80M Carmel Expansion

      Carmel-based KAR Auction Services Inc. (NYSE: KAR) has announced a headquarters expansion that is expected to create 400 jobs by 2020. The company plans to invest $80 million into what it says will be a state-of-the-art campus to house 1,500 workers. During an announcement Tuesday at the Center for the Performing Arts, Chief Executive Officer Jim Hallett said...

    • Cook Creates 'Really Big Day in Bloomington'

      The president of Bloomington-based Cook Group Inc. says Tuesday's agreement to sell its Cook Pharmica LLC subsidiary to New Jersey-based Catalent Inc. (NYSE: CTLT) and the decision to acquire a former General Electric facility near the company's headquarters will have a positive impact on the city and state. Pete Yonkman says the nearly $1 billion dollar deal for Cook Pharmica has been six months in the making.